XML 55 R35.htm IDEA: XBRL DOCUMENT v3.25.1
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Feb. 02, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense, Net of Estimated Forfeitures
The following table presents total stock-based compensation expense, net of estimated forfeitures, including expense related to our ESPPs, and related income tax benefit:
in millionsFiscalFiscalFiscal
202420232022
Pre-tax stock-based compensation expense$444 $382 $367 
Income tax benefit(92)(79)(73)
After-tax stock-based compensation expense$352 $303 $294 
Schedule of Option Valuation Assumptions
The following table presents the per share weighted average fair value of stock options granted and the assumptions used in determining fair value at the date of grant using the Black-Scholes option-pricing model: 
 FiscalFiscalFiscal
 202420232022
Per share weighted average fair value$95.50 $66.01 $70.21 
Risk-free interest rate4.2 %3.6 %2.5 %
Expected volatility
24.6 %26.7 %27.0 %
Dividend yield
2.4 %2.8 %2.4 %
Expected term
6 years6 years6 years
Schedule of Option Activity by Number of Shares and Weighted Average Exercise Price
The following table presents a summary of stock option activity by number of shares and weighted average exercise price during fiscal 2024:
shares in thousandsNumber of
Shares
Weighted Average
Exercise Price
Outstanding at beginning of year3,085 $189.97 
Granted175 383.15 
Exercised(1,036)138.64 
Forfeited(23)306.00 
Outstanding at end of year2,201 228.23 
Intrinsic Value of Stock Options Exercised
The following table presents the total intrinsic value of stock options exercised:
in millionsFiscalFiscalFiscal
202420232022
Total intrinsic value of stock options exercised$254 $152 $61 
Schedule of Options Outstanding and Exercisable
The following table presents details regarding outstanding and exercisable stock options at February 2, 2025:
shares in thousands, dollars in millions, except for per share amountsNumber of
Shares
Intrinsic
Value
Weighted Average
Remaining Life
Weighted Average
Exercise Price
Outstanding2,201 $404 5.0 years$228.23 
Exercisable1,411 320 3.6 years185.43 
Schedule of Restricted Stock and Restricted Stock Unit Activity
The following table presents a summary of restricted stock and restricted stock unit activity during fiscal 2024:
shares in thousandsNumber of
Shares
Weighted Average
Grant Date Fair Value
Nonvested at beginning of year3,033 $277.09 
Granted (1)
1,330 375.21 
Vested(1,113)260.05 
Forfeited(200)315.04 
Nonvested at end of year3,050 323.61 
—————
(1)    Includes replacement restricted stock awards with service-based vesting conditions issued in connection with the SRS acquisition (see Note 13).
Schedule of total fair value of restricted stock, performance shares, and restricted stock units that vested
The following table presents the total fair value of restricted stock and restricted stock units vested:
in millionsFiscalFiscalFiscal
202420232022
Total fair value vested$429 $312 $387 
The following table presents the total fair value of performance shares vested:
in millionsFiscalFiscalFiscal
202420232022
Total fair value vested$83 $100 $92 
Schedule of Share-Based Payment Award, Performance Shares, Valuation Assumptions
The following table presents the per share weighted average fair value and the assumptions used in the Monte Carlo simulation for the market-based awards:
 Fiscal
 2024
Per share weighted average fair value$125.92 
Risk-free interest rate4.1 %
Expected volatility
25.4 %
Dividend yield
2.5 %
Award term
5 years
Schedule of Performance Share Activity
The following table presents a summary of performance share activity during fiscal 2024:
shares in thousandsNumber of
Shares
Weighted Average
Grant Date Fair Value
Nonvested at beginning of year353 $297.25 
Granted (1)
1,146 295.30 
Vested
(223)292.75 
Forfeited(68)293.86 
Nonvested at end of year1,208 296.42 
—————
(1)    Includes performance share awards issued in relation to the SRS acquisition.
Schedule of deferred shares granted
The following table presents deferred shares granted to non-employee directors:
shares in thousands
FiscalFiscalFiscal
202420232022
Deferred shares granted to non-employee directors15 19 19